|
Symbol
|
CDOBKB | RMBCYV | KYYLDU | KYYIDU | KZAKDU | PDDRCH | KZCTDU | KYZFDU | RMA6TV | ABJYTQ | KZFFDU | KZCJDU | KZEGDU | ABNKTQ | RMAWAV | RMAO3V | KZKQDU | KZLKDU | RMAVRV | PMSRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible |
|
Underlying
|
Compagnie Financière Richemont SA / Julius Baer Group / Nestlé S.A. / Novartis AG / Roche PS | Compagnie Financière Richemont SA / Givaudan / Nestlé S.A. / Novartis AG / Roche PS | Compagnie Financière Richemont SA / Partners Group Hldg. AG | Compagnie Financière Richemont SA / Nestlé S.A. / Roche PS | Companie Financière Richemont SA / Dufry AG / Givaudan | Companie Financière Richemont SA / Givaudan / Nestlé N | Companie Financière Richemont SA / Givaudan / Nestlé N | Companie Financière Richemont SA / Swatch Group I | Companie Financière Richemont SA / Dufry AG / Logitech International SA | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Companie Financière Richemont SA / Dufry AG / Givaudan | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Straumann Hldg. AG | Barry Callebaut AG / Companie Financière Richemont SA / Givaudan | Barry Callebaut AG / Companie Financière Richemont SA / Givaudan | Aryzta AG / Compagnie Financière Richemont SA / Sandoz Group AG | Compagnie Financière Richemont SA / Partners Group Hldg. AG / Roche PS | Compagnie Financière Richemont SA / Holcim/Amrize Basket / Swiss RE AG | Compagnie Financière Richemont SA / Partners Group Hldg. AG / Roche PS | Compagnie Financière Richemont SA / Holcim/Amrize Basket / Swiss RE AG | ABB / Compagnie Financière Richemont SA / Novartis AG / Partners Group Hldg. AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
30.08.2027 | 11.03.2027 | 16.10.2026 | 16.10.2026 | 30.10.2026 | 04.11.2026 | 13.11.2026 | 23.10.2026 | 02.11.2026 | 12.05.2027 | 27.11.2026 | 06.11.2026 | 20.11.2026 | 02.12.2026 | 21.12.2026 | 29.12.2026 | 15.01.2027 | 15.01.2027 | 21.12.2026 | 20.01.2027 |
| Bid | 99.21 | 97.20 | 45.750 | 99.55 | 81.70 | 101.31 | 98.95 | 99.70 | 99.70 | 100.83 | 100.30 | 98.70 | 77.35 | 79.42 | 59.70 | 49.800 | 100.40 | 46.800 | 99.60 | 48.160 |
| Ask | 100.01 | 98.40 | 46.750 | 100.60 | 82.70 | - | - | 100.70 | 100.90 | 101.64 | 101.30 | 99.70 | 78.35 | - | - | - | 101.40 | 47.800 | 100.60 | - |